[ Price : $8.95]
FDA grants fast track designation for Pfizers ervogastat/clesacostat combination drug being developed to treat non-alcoholic steat...[ Price : $8.95]
FDA grants Tvardi Therapeutics an orphan drug designation for TTI-101 for treating idiopathic pulmonary fibrosis.[ Price : $8.95]
FDA approves Serviers Tibsovo, indicated for treating some new acute myeloid leukemia cases, six weeks ahead of its goal date.[ Price : $8.95]
FDA accepts for priority review a Reata Pharmaceuticals NDA for omaveloxolone for treating patients with Friedreichs ataxia.[ Price : $8.95]
U.S. Senators Joe Manchin (D-WV) and Mike Braun (R-IN) introduce the Ensuring the FDA Fully Examines Clinical Trial Impact and Vit...[ Price : $8.95]
A Friends of Cancer Research-funded analysis shows a positive correlation between drugs receiving a breakthrough therapy designati...[ Price : $8.95]
Attorney Nancy Taylor asks FDA to take steps to increase the use of OTC external analgesics in pain management.[ Price : $8.95]
FDA says an Abbott recall of specific lots of its Dragonfly OpStar imaging catheter due to a potential loose marker band is Class ...